BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36180855)

  • 1. Renal histopathological lesions after liver transplantation: What can we find besides calcineurin inhibitor-induced nephrotoxicity?
    Jin H; Wei Y; Qian Y; Zhang J; Xu Y; Zhou H; Zhang M; Zhou W; Qi C; Jin W; Mou S; Wang Q; Zhang J
    BMC Nephrol; 2022 Sep; 23(1):324. PubMed ID: 36180855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Key role of renal biopsy in management of progressive chronic kidney disease in liver graft recipients.
    Welker MW; Weiler N; Bechstein WO; Herrmann E; Betz C; Schöffauer M; Zeuzem S; Sarrazin C; Amann K; Jung O
    J Nephrol; 2019 Feb; 32(1):129-137. PubMed ID: 29946864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of chronic kidney disease progression used by calcineurin inhibitor concentration and estimated glomerular filtration rate early after liver transplantation.
    Ye L; Zhang Y; Tang H; Yao J; Wang G; Yang Y; Chen G
    Niger J Clin Pract; 2020 Oct; 23(10):1387-1394. PubMed ID: 33047695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological study of renal biopsies after liver transplantation.
    Chan GS; Lam MF; Kwan L; Fung SH; Chan SC; Chan KW
    Hong Kong Med J; 2013 Feb; 19(1):27-32. PubMed ID: 23378351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Renal Histological Correlates of Refractory Renal Dysfunction After Liver Transplantation.
    Choudhary NS; Dhampalwar S; Saraf N; Bansal SB; Gadde A; Rastogi A; Bhangui P; Rana A; Rana A; Soin AS
    J Clin Exp Hepatol; 2023; 13(4):586-591. PubMed ID: 37440946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study on renal biopsy before and after long-term calcineurin inhibitors therapy: an insight for pathogenesis of its toxicity.
    Singh L; Singh G; Sharma A; Sinha A; Bagga A; Dinda AK
    Hum Pathol; 2015 Jan; 46(1):34-9. PubMed ID: 25449629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcineurin inhibitor-induced chronic nephrotoxicity in liver transplant patients is reversible using rapamycin as the primary immunosuppressive agent.
    Cotterell AH; Fisher RA; King AL; Gehr TW; Dawson S; Sterling RK; Stravitz RT; Luketic VA; Sanyal AJ; Shiffman ML; Posner MP
    Clin Transplant; 2002; 16 Suppl 7():49-51. PubMed ID: 12372044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal histopathological lesions after orthotopic liver transplantation (OLT).
    Pillebout E; Nochy D; Hill G; Conti F; Antoine C; Calmus Y; Glotz D
    Am J Transplant; 2005 May; 5(5):1120-9. PubMed ID: 15816895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic study of kidney biopsies in patients before or after liver transplant.
    Terzi A; Özdemir BH; Taşlıca FZ; Özdemir FN; Kırnap M; Haberal M
    Exp Clin Transplant; 2014 Mar; 12 Suppl 1():129-35. PubMed ID: 24635810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical usefulness of kidney biopsy in liver transplant recipients with renal impairment.
    Lee JH; Cho YH; Ryu SJ; Kim SS; Lee YH; Jang IA; Choi BS; Choi JY; Kim DG; Choi YJ; Yang CW; Chung BH
    Kidney Res Clin Pract; 2013 Dec; 32(4):153-7. PubMed ID: 26877934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylaxis of chronic kidney disease after liver transplantation--experience from west China.
    Shao ZY; Yan LN; Wang WT; Li B; Wen TF; Yang JY; Xu MQ; Zhao JC; Wei YG
    World J Gastroenterol; 2012 Mar; 18(9):991-8. PubMed ID: 22408361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A longitudinal study of long-term renal outcome after pediatric liver transplantation in relation to CNI exposure.
    Vandewiele S; Herman J; van den Heuvel L; Knops N
    Pediatr Transplant; 2024 Feb; 28(1):e14677. PubMed ID: 38149466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity.
    Flechner SM; Kobashigawa J; Klintmalm G
    Clin Transplant; 2008; 22(1):1-15. PubMed ID: 18217899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic Kidney Disease in Patients After Liver Transplantation: A Long-Term Retrospective Analysis From 1 Transplantation Center.
    Gojowy D; Kubis P; Gorecka M; Karkoszka H; Wiecek A; Adamczak M
    Transplant Proc; 2020 Oct; 52(8):2492-2496. PubMed ID: 32249052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Postoperative Neutrophil Gelatinase-Associated Lipocalin Predicts the Development of Chronic Kidney Disease After Liver Transplantation.
    Cullaro G; Pisa JF; Brown RS; Wagener G; Verna EC
    Transplantation; 2018 May; 102(5):809-815. PubMed ID: 29300232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney Biopsies May Help Predict Renal Function After Liver Transplantation.
    Pichler RH; Huskey J; Kowalewska J; Moiz A; Perkins J; Davis CL; Leca N
    Transplantation; 2016 Oct; 100(10):2122-8. PubMed ID: 27479161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD44 as a pathological marker for the early detection of calcineurin inhibitor-induced nephrotoxicity post kidney transplantation.
    Hayashi A; Okamoto T; Nio-Kobayashi J; Iwahara N; Suzuki R; Ueda Y; Takahashi T; Yasuyuki Sato ; Iwanaga T; Hotta K
    Biomed Res; 2022; 43(5):181-186. PubMed ID: 36244796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Renal Function in Liver Transplant Recipients After Conversion From Calcineurin Inhibitors to mTOR Inhibitors.
    Hüsing A; Schmidt M; Beckebaum S; Cicinnati VR; Koch R; Thölking G; Stella J; Heinzow H; Schmidt HH; Kabar I
    Ann Transplant; 2015 Nov; 20():707-13. PubMed ID: 26608590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-CD25 monoclonal antibody replacement therapy for chronic kidney disease in liver transplant recipients.
    Walsh C; Barkun J; Tchervenkov J; Deschenes M; Ghali P; Wong P; Chaudhury P; Paraskevas S; Metrakos P; Cantarovich M
    Transplantation; 2013 Feb; 95(3):495-500. PubMed ID: 23296149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion from calcineurin inhibitor to either mycophenolate mofetil or sirolimus improves renal function in liver transplant recipients with chronic kidney disease: results of a prospective randomized trial.
    Herlenius G; Felldin M; Nordén G; Olausson M; Bäckman L; Gustafsson B; Friman S
    Transplant Proc; 2010 Dec; 42(10):4441-8. PubMed ID: 21168715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.